JP2022538789A5 - - Google Patents

Info

Publication number
JP2022538789A5
JP2022538789A5 JP2021573843A JP2021573843A JP2022538789A5 JP 2022538789 A5 JP2022538789 A5 JP 2022538789A5 JP 2021573843 A JP2021573843 A JP 2021573843A JP 2021573843 A JP2021573843 A JP 2021573843A JP 2022538789 A5 JP2022538789 A5 JP 2022538789A5
Authority
JP
Japan
Prior art keywords
crispr
nucleic acid
related protein
target nucleic
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021573843A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022538789A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/037585 external-priority patent/WO2020252378A1/en
Publication of JP2022538789A publication Critical patent/JP2022538789A/ja
Publication of JP2022538789A5 publication Critical patent/JP2022538789A5/ja
Pending legal-status Critical Current

Links

JP2021573843A 2019-06-14 2020-06-12 新規crispr dnaターゲティング酵素及びシステム Pending JP2022538789A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962861582P 2019-06-14 2019-06-14
US62/861,582 2019-06-14
US201962872157P 2019-07-09 2019-07-09
US62/872,157 2019-07-09
US201962873602P 2019-07-12 2019-07-12
US201962873606P 2019-07-12 2019-07-12
US62/873,602 2019-07-12
US62/873,606 2019-07-12
PCT/US2020/037585 WO2020252378A1 (en) 2019-06-14 2020-06-12 Novel crispr dna targeting enzymes and systems

Publications (2)

Publication Number Publication Date
JP2022538789A JP2022538789A (ja) 2022-09-06
JP2022538789A5 true JP2022538789A5 (cg-RX-API-DMAC7.html) 2023-06-19

Family

ID=73781310

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573843A Pending JP2022538789A (ja) 2019-06-14 2020-06-12 新規crispr dnaターゲティング酵素及びシステム

Country Status (7)

Country Link
US (1) US20220315913A1 (cg-RX-API-DMAC7.html)
EP (1) EP3983536A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022538789A (cg-RX-API-DMAC7.html)
CN (1) CN114269912A (cg-RX-API-DMAC7.html)
AU (1) AU2020291467A1 (cg-RX-API-DMAC7.html)
CA (1) CA3142019A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020252378A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4025588A4 (en) * 2019-09-05 2023-09-06 Arbor Biotechnologies, Inc. NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS
US20240093228A1 (en) * 2021-01-22 2024-03-21 Arbor Biotechnologies, Inc. Compositions comprising a nuclease and uses thereof
AU2022284804A1 (en) 2021-06-01 2023-12-07 Arbor Biotechnologies, Inc. Gene editing systems comprising a crispr nuclease and uses thereof
US20260232844A1 (en) 2023-02-15 2026-08-13 Arbor Biotechnologies, Inc. Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript
WO2025171210A1 (en) 2024-02-09 2025-08-14 Arbor Biotechnologies, Inc. Compositions and methods for gene editing via homology-mediated end joining
WO2025201481A1 (en) * 2024-03-29 2025-10-02 Yoltech Therapeutics Co., Ltd Crispr-cas systems
WO2026015829A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Small reverse transcriptases and gene editing systems comprising such
WO2026015832A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Reverse transcriptases and gene editing systems comprising such

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9074199B1 (en) * 2013-11-19 2015-07-07 President And Fellows Of Harvard College Mutant Cas9 proteins
WO2017044776A1 (en) * 2015-09-10 2017-03-16 Texas Tech University System Single-guide rna (sgrna) with improved knockout efficiency
CN109688820B (zh) * 2016-06-24 2023-01-10 科罗拉多州立大学董事会(法人团体) 用于生成条形码化组合文库的方法
AU2017388379A1 (en) * 2016-12-28 2019-06-06 Ionis Pharmaceuticals, Inc. Modified CRISPR RNA and uses thereof
US9982279B1 (en) * 2017-06-23 2018-05-29 Inscripta, Inc. Nucleic acid-guided nucleases
WO2019051419A1 (en) * 2017-09-08 2019-03-14 University Of North Texas Health Science Center Engineered cas9 variants
US20200255829A1 (en) * 2017-11-02 2020-08-13 Arbor Biotechnologies, Inc. Novel crispr-associated transposon systems and components

Similar Documents

Publication Publication Date Title
US11459588B2 (en) Methods of use of CRISPR CPF1 hybrid DNA/RNA polynucleotides
JP2022540153A5 (cg-RX-API-DMAC7.html)
JP2022547524A5 (cg-RX-API-DMAC7.html)
JP2025161809A5 (cg-RX-API-DMAC7.html)
JP2022546594A5 (cg-RX-API-DMAC7.html)
CN111836894B (zh) 用于使用CRISPR/Cpf1系统进行基因组编辑的组合物及其用途
JP2022546701A5 (cg-RX-API-DMAC7.html)
EP3802802A1 (en) Cell therapy
FI3802807T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi
FI4118198T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja käyttömenetelmiä
FI3765615T3 (fi) Uusia DNA:han kohdentuvia CRISPR-entsyymejä ja järjestelmiä
JP2021530988A5 (cg-RX-API-DMAC7.html)
JP2024524514A5 (cg-RX-API-DMAC7.html)
CA3163087A1 (en) System and method for activating gene expression
US20200224194A1 (en) Expression systems that facilitate nucleic acid delivery and methods of use
US20240279687A1 (en) Peptide nucleic acids for spatiotemporal control of crispr-cas binding
WO2025199534A1 (en) New r2 retrotransposons for gene writing
HK40102346A (en) Crispr hybrid dna/rna polynucleotides and methods of use
WO2024091907A1 (en) Compositions and methods for modifying the hpv16 genome
HK1245839B (en) Crispr hybrid dna/rna polynucleotides and methods of use